Scientists scan brains to uncover hidden links between movement and mood in rare disorder
NCT ID NCT05671068
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at how the cerebellum is involved in movement, thinking, and emotions in people with myoclonus dystonia, a rare movement disorder. Researchers used MRI scans to compare brain activity in 47 participants while they performed small tasks. The goal was to better understand why many patients also experience psychiatric symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could help scientists understand why people with myoclonus dystonia often have psychiatric symptoms, possibly pointing toward better treatments in the future.
- What could go wrong
- This is a small, completed observational study with only 47 participants. It was not designed to test a treatment, so any insights are preliminary and may not lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
47 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Feb 2024
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study will enroll patients with DYT-SGCE and Healthy Volunteers (HVs).
- Ages
-
15 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: For all participants: * Age between 15-60 years * Able to give informed consent. For patients: * An established diagnostic of DYT-SGCE * No change in medication (related to DYT-SGCE) for a month For controls: * No neurological symptoms * No medication except oral contraception Exclusion Criteria: * No deprivation of liberty * Inability to give a consent * Established cognitive alteration * Contraindication to MRI (per MRI safety checklist) * Severe chronic psychiatric illness
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYT11 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brain Institute
Paris, Paris, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.